Showing results (231-240 of 272) with videos related to
Sort By:
Pageof 28
Alimentary Pharmacology & Therapeutics|November 9, 2011
Fatigue in out-patients with inflammatory bowel disease is common and multifactorialP Bager, R Befrits, O Wikman, et al.European Urology|August 2, 2020
The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomised Controlled TrialMaria S Lindgren, Peter Bue, Nessn Azawi, et al.Journal of Internal Medicine|March 19, 1999
Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patientsH Verbaan, J Carlson, S Eriksson, et al.Scandinavian Journal of Urology|January 31, 2022
The transferability of the minimal invasive surgeon's skills to open surgeryMaria Ordell Sundelin, Charlotte Paltved, Pernille Skjold Kingo, et al.Scandinavian Journal of Gastroenterology|February 15, 2000
Alpha1-antitrypsin deficiency may be a risk factor for duodenal ulcer in patients with Helicobacter pylori infectionA N Elzouki, E Tóth, C H Florén, et al.Journal of Virology|October 9, 1999
The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapyC Tscherning-Casper, N Papadogiannakis, M Anvret, et al.Scandinavian Journal of Infectious Diseases|March 10, 2001
HIV-1 in placentas of untreated HIV-1-infected women in relation to viral transmission, infectious HIV-1 and RNA load in plasmaM Dictor, S Lindgren, J Bont, et al.Journal of Cardiovascular Electrophysiology|June 5, 2003
Heart rate turbulence after ventricular and atrial premature beats in subjects without structural heart diseaseKai S Lindgren, Timo H Mäkikallio, Tapio Seppänen, et al.BMJ (Clinical Research Ed.)|December 4, 1993
Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programmeS Lindgren, A B Bohlin, M Forsgren, et al.Neurobiology of Disease|November 13, 2007
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiationBarbara Picconi, Vincent Paillé, Veronica Ghiglieri, et al.Pageof 28